Početna › Rak štitnjače › Texas
Kliničke studije za Rak štitnjače u državi Texas
15 studija za Rak štitnjače traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Dallas
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06507878Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT05786924Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
- The University of Texas M. D. Anderson Cancer Center, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT07218315Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06959511Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 2
Od 2 do 25 godina · Oba spola · Ažurirano 24. srp 2026. · NCT06458036A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
- M D Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 22. svi 2026. · NCT04589624Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT06239194Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- M D Anderson Cancer Center, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 15. tra 2026. · NCT04693377cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 godina i više · Oba spola · Ažurirano 20. sij 2026. · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 2
Od 2 do 99 godina · Oba spola · Ažurirano 14. stu 2025. · NCT05783323Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
- University of Texas Health Science Center, San Antonio
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 15. lis 2025. · NCT03160274Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 12. pro 2024. · NCT05668962Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.